Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.33M | 49.21M | 57.17M | 48.53M | 63.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.19M | 1.23M | 1.32M | 1.71M | 2.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 213.00K | 181.00K | 181.00K | 181.00K | 181.00K |
| Total Current Assets | 19.73M | 50.62M | 58.67M | 50.41M | 67.06M |
|
|
|||||
| Total Current Assets | 19.73M | 50.62M | 58.67M | 50.41M | 67.06M |
| Net Property, Plant & Equipment | 261.00K | 949.00K | 1.05M | 311.00K | 345.00K |
| Long-term Investments | -- | 10.89M | 10.75M | 10.99M | 11.11M |
| Goodwill | -- | 10.89M | 10.75M | 10.99M | 11.11M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.50M | 45.17M | 44.59M | 45.59M | 46.11M |
| Total Assets | 43.49M | 107.63M | 115.05M | 107.31M | 124.63M |
|
|
|||||
| Total Accounts Payable | 1.83M | 1.52M | 2.18M | 2.79M | 3.48M |
| Total Accrued Expenses | 2.88M | 4.73M | 5.05M | 7.84M | 10.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 175.00K | 289.00K | 327.00K | -- | -- |
| Total Finance Division Other Current Liabilities | 45.00K | 14.27M | 14.90M | 13.71M | 213.00K |
| Total Other Current Liabilities | 45.00K | 14.27M | 14.90M | 13.71M | 213.00K |
| Total Current Liabilities | 4.93M | 20.81M | 22.45M | 24.35M | 13.81M |
|
|
|||||
| Total Current Liabilities | 4.93M | 20.81M | 22.45M | 24.35M | 13.81M |
| Long-Term Debt | 10.10M | 29.47M | 29.24M | 30.13M | 29.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 544.00K | 587.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.36M | 29.81M | 29.49M | 26.25M | 35.91M |
| Total Liabilities | 20.39M | 80.64M | 81.77M | 80.73M | 79.70M |
|
|
|||||
| Common Stock & APIC | 209.82M | 208.26M | 206.89M | 182.75M | 181.11M |
| Retained Earnings | -188.02M | -184.05M | -175.79M | -159.37M | -140.03M |
| Treasury Stock & Other | 1.30M | 2.77M | 2.19M | 3.20M | 3.86M |
| Total Common Equity | 23.10M | 26.98M | 33.29M | 26.58M | 44.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.10M | 26.98M | 33.29M | 26.58M | 44.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.10M | 26.98M | 33.29M | 26.58M | 44.93M |
|
|
|||||